PortfoliosLab logoPortfoliosLab logo
SBU vs. BIS
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SBU vs. BIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Leverage Shares 2X Long SBUX Daily ETF (SBU) and ProShares UltraShort Nasdaq Biotechnology (BIS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBU achieves a 21.72% return, which is significantly higher than BIS's -10.87% return.


SBU

1D
0.85%
1M
-16.51%
YTD
21.72%
6M
11.90%
1Y
3Y*
5Y*
10Y*

BIS

1D
-4.83%
1M
-2.10%
YTD
-10.87%
6M
-8.91%
1Y
-52.09%
3Y*
-22.48%
5Y*
-15.34%
10Y*
-23.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBU vs. BIS - Yearly Performance Comparison


Correlation

The correlation between SBU and BIS is -0.26, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (All Time)
Calculated using the full available price history since Nov 18, 2025

-0.26

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBU vs. BIS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBU

BIS
BIS Risk / Return Rank: 11
Overall Rank
BIS Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BIS Sortino Ratio Rank: 11
Sortino Ratio Rank
BIS Omega Ratio Rank: 11
Omega Ratio Rank
BIS Calmar Ratio Rank: 11
Calmar Ratio Rank
BIS Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBU vs. BIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 2X Long SBUX Daily ETF (SBU) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

SBU vs. BIS - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


SBUBISDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.71

-0.68

+1.38

Drawdowns

SBU vs. BIS - Drawdown Comparison

The maximum SBU drawdown since its inception was -28.10%, smaller than the maximum BIS drawdown of -99.87%. Use the drawdown chart below to compare losses from any high point for SBU and BIS.


Loading charts...

Drawdown Indicators


SBUBISDifference

Max Drawdown

Largest peak-to-trough decline

-28.10%

-99.87%

+71.77%

Max Drawdown (1Y)

Largest decline over 1 year

-54.50%

Max Drawdown (3Y)

Largest decline over 3 years

-66.87%

Max Drawdown (5Y)

Largest decline over 5 years

-74.80%

Max Drawdown (10Y)

Largest decline over 10 years

-95.25%

Current Drawdown

Current decline from peak

-20.00%

-99.86%

+79.86%

Average Drawdown

Average peak-to-trough decline

-6.56%

-90.03%

+83.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.73%

Volatility

SBU vs. BIS - Volatility Comparison


Loading charts...

Volatility by Period


SBUBISDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.76%

Volatility (6M)

Calculated over the trailing 6-month period

31.31%

Volatility (1Y)

Calculated over the trailing 1-year period

59.78%

39.91%

+19.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.78%

43.78%

+16.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.78%

46.38%

+13.40%

SBU vs. BIS - Expense Ratio Comparison

SBU has a 0.75% expense ratio, which is lower than BIS's 0.95% expense ratio.


Dividends

SBU vs. BIS - Dividend Comparison

SBU has not paid dividends to shareholders, while BIS's dividend yield for the trailing twelve months is around 5.17%.


PositionTTM20252024202320222021202020192018
BIS
ProShares UltraShort Nasdaq Biotechnology
5.17%5.25%3.73%1.75%0.00%0.00%0.45%2.11%0.37%
SBU
Leverage Shares 2X Long SBUX Daily ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


SBU and BIS have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, SBU is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

SBU is cheaper with a 0.75% expense ratio, compared with 0.95% for BIS.

BIS has the higher dividend yield at 5.17%, compared with 0.00% for SBU.

They also come from different issuers: Leverage Shares and ProShares. Their fees differ too: 0.75% for SBU and 0.95% for BIS.

Portfolio Optimizer

Find the right allocation for SBU and BIS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer